DSIP vs Semax
Emerging vs Well Studied
compatible Different mechanisms; can optimize 24-hour function.
Molecular Data
DSIP Semax
Weight 848.81 Da 813.93 Da
Half-life ~15 minutes (in vitro) 0.5-2 hours
Chain 9 amino acids 7 amino acids
Type Nonapeptide ACTH(4-10) synthetic analog
Key Benefits
DSIP
01 Enhanced sleep quality through slow-wave sleep promotion
02 Stress reduction via cortisol modulation
03 Potential pain relief
04 Mood stabilization without traditional sedative effects
05 No tolerance or dependence reported
06 Short cycle duration (5-10 days)
Semax
01 Rapid brain delivery via intranasal route
02 Rapidly increases BDNF levels
03 Extensive clinical research in Russia
04 Easy self-administration
05 Modulates dopamine and serotonin systems
06 Neuroprotective effects
Dosing Protocols
DSIP
100-300mcg / 1x daily
Sleep enhancement 100-200mcg Once nightly
Chronic pain support 250-300mcg Daily
Stress management 150mcg Evening
Withdrawal support 200-300mcg Twice daily
Athletic recovery 100-150mcg Post-training
Semax
300-600mcg per dose (up to 1000mcg for intensive use) / 1-2x daily (morning recommended for cognitive boost)
Research protocol 500-750mcg 1x daily
Intensive protocol 750-1000mcg 1-2x daily
Side Effects
DSIP
Generally well-tolerated with minimal side effects
Mild drowsiness or dizziness initially (some users)
Occasional headaches in sensitive individuals
No tolerance or dependence reported in studies
Semax
Mild nasal discomfort (nasal route)
Possible nasal sensation upon administration
Contraindications
Avoid driving until effects are known
Pregnancy or breastfeeding
Pregnancy or breastfeeding
Known peptide allergies
Do not exceed 4-week continuous use without medical supervision
Research Evidence
DSIP Semax
Status Emerging Well Studied
References 5 studies 4 studies
Latest 2024 2021
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.